Development of obsessive and depressive symptoms during risperidone treatment.
Bakaras
P
P
Georgoussi
M
M
Liakos
A
A
Panagiotis
B
B
Maria
G
G
Aris
L
L
D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects*; D003863:Depression / Q000139:chemically induced*; D006801:Humans; D008297:Male; D009771:Obsessive-Compulsive Disorder / Q000139:chemically induced*; D018967:Risperidone / Q000009:adverse effects*
D014150:Antipsychotic Agents; D018967:Risperidone